COVID-19

Pfizer seeking approval for COVID booster

The Portage-based pharmaceutical company says people are better protected against COVID with a six month booster of its vaccine.

Pfizer plans to ask the U.S. Food and Drug Administration to authorize a COVID-19 booster shot. The company, which manufactures one of the existing coronavirus vaccines at its facilities in Portage, believes another shot could help patients ward off COVID-19.

What Happened: Pfizer plans to meet with federal officials this week to discuss the authorization request. A formal request could come as soon as next month.

Sign up for our daily newsletter

A weekday morning email roundup of Kalamazoo stories and events.

Context: Not much is known about the long-term efficacy of the coronavirus vaccine. So far protection has lasted months, but immunization might wane over time.

Medical experts at Pfizer have said the number of antibodies jump five or ten times after a third shot of the Pfizer vaccine.

What They’re Saying: Dr. Richard Van Enk, the director of epidemiology and infection prevention at Bronson Healthcare, told WOOD TV 8 that a booster shot isn’t needed yet.

“The way that the pharmaceutical companies are approaching this is to prepare for something that may be necessary in the future – it’s not to respond to a situation that’s a real need today,” he said.

You can read more here.

Support local. Donate today to Kalamazoo's only locally owned and independent daily news organization.